LitInspector: Quick And Easy Retrieval Of Pathways, Genes, Gene Functions, Gene-Gene Interactions And More
Main Category: IT / Internet / E-mailAlso Included In: Genetics
Article Date: 29 Nov 2007 - 3:00 PDT
| Patient / Public: | ![]() |
4.75 (4 votes) |
| Healthcare Prof: | ![]() |
5 (10 votes) |
Genomatix Software GmbH of Munich, Germany and its US branch Genomatix Software, Inc. in Ann Arbor, MI (USA) has announced the release of LitInspector.
LitInspector can be accessed without limits and free of charge by the scientific community world wide. All that is required is registration for a free evaluation account for the Genomatix Portal from http://www.genomatix.de11/28/2007 or http://www.genomatix-software.com/.
LitInspector is a powerful literature and pathway mining system based on all published abstracts and related meta-information (like MeSH) from entire PubMed of the National Library of Medicine. With more than 260,000 gene synonyms, LitInspector uses one of the largest gene synonym tables available, thus securing a substantial amount of relevant information for scientists not knowing all synonyms of their gene of interest. Additional free text input and boolean operators allow for focussed literature searches.
MeSH term and keyword classifiers like "disease", "tissue", or "pathway" lead to comprehensive results within seconds.
More than 1.6 million gene-gene relations are pre-analyzed. Pathway associations and links to KEGG, STKE and BioCarta are provided.
At each step, LitInspector optionally branches out into Genomatix´ integrated suite of systems biology databases and analysis technology, such as the ElDorado genomic annotation database.
"Why are we giving away LitInspector free of charge to everybody?" asks Klaus J.W. May, Chief Business Officer of Genomatix Software GmbH. "We have several reasons", he answers his own question. "LitInspector´s power and broad applicability reaches way beyond our existing user base. It is a tool which can and should be used by any life science researcher looking up literature for genes, diseases, or pathways." he continues.
"Secondly, LitInspector is a proof of our expertise and the extremely rich content which we have developed over the last ten years. LitInspector has been used in-house as a stepping stone for the development of our BiblioSphere PathwayEdition gene regulatory pathway and networks mining tool for several years now. Why hide it away from the public" Genomatix has such a wealth of quality checked content, not immediately evident. E.g. our ElDorado genomic annotation database surpasses any public domain gene browser at least by the factor of five in number of transcripts and regulatory regions, plus tons of data not available anywhere else. I count on LitInspector further raising the awareness of Genomatix", he concludes.
###
About Genomatix:
Genomatix is a pioneer and leader in the analysis and understanding of eukaryotic gene regulation. Core competences at Genomatix are annotation driven microarray analysis, ChIP on chip, regulatory network and pathway mining, and promoter analysis on sequence level. Genomatix provides some of the largest data bases for genomic annotation and transcription factors. Genomatix has published more than 170 peer reviewed scientific papers.
Source: Klaus May
Genomatix Software GmbH
Visit our it / internet / e-mail section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/90172.php>
APA
http://www.medicalnewstoday.com/releases/90172.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



